4A: PANEL: Meet The Editors of Biomaterials Journals

Date: Thursday, March 26, 2026
Time: 1:30 PM to 3:30 PM
Room: Centennial III/IV

Description

This panel will include a moderated discussion with editors of several biomaterials journals on current challenges and issues relevant to publishing.

4B: Biomaterials for Regenerative Engineering 1

Date: Thursday, March 26, 2026
Time: 1:30 PM to 3:30 PM
Room: Centennial I

Description

Moderators:

Kent Leach
Professor | Biomedical Engineering | Orthopaedic Surgery
UC Davis Biomedical Engeineering

Uta Göebel
Wiley

  • 1:30 PM. 165. Regenerative Engineering: Materials in Convergence. Dr. Cato Laurencin, University of Connecticut Speakers Dr. Cato Laurencin
  • 2:00 PM. 166. Engineered Self-Oxygenating Biomaterials for Enhanced Regeneration.Gulden Camci-Unal, PhD1 1University of Massachusetts Lowell
  • 2:15 PM. 167. Growth factor binding via click chemistry enhances cell-secreted extracellular matrix osteogenic potential.Shierly Fok1, David Ramos-Rodriguez2, Advait Bhagvat2, Nikolia Kruger2, Mason Caserta1, Thai Thanh Hoang1, J. Kent Leach1 1UC Davis Health, 2UC Davis
  • 2:30 PM. 168. Young Extracellular Matrix-Based Scaffolds and Transplants Drive Enhanced Skin Wound Healing.Tailynn McCarty1, Laura Casado Mayo1, Cathal Kearney1 1University of Massachusetts Amherst
  • 2:45 PM. 169. NorHA-based Fiber-Enhanced Microparticle (FEMP) Scaffolds for Regenerative Repair of Breast Cancer Tumor Resection Cavities.Natasha Claxton, Ph.D.1, Chris Highley, Ph.D.2, Matthew DeWitt, Ph.D.2, Remington Martinez, B.S.2, Jack Whitewolf, Ph.D.2, Patrick Cottler, Ph.D.2, Lisa Salopek, B.S.2, Helen Billcheck, B.S.2, Anna Dugan, B.S.2 1Tulane University, 2University of Virginia
  • 3:00 PM. 170. Chiral Nanoparticles Drive Enantiomer-specific Osteogenesis and Accelerate Stem Cell-based Bone Regeneration.Yuwen Wang1, Zheng Zhong1, Zeqing Li2, Maobin Xie2, Chunying Chen3, Zhong Alan Li1 1The Chinese University of Hong Kong, 2Guangzhou Medical University, 3University of Chinese Academy of Sciences
  • 3:15 PM. 171. Infusible Extracellular Matrix Biomaterial as a Dual-Therapeutic Targeting Platform in Inflammatory Injury.Emily Gardner1, Alex Chen1, Michael Nguyen, PhD2, Rebecca Braden1, Karen Christman, PhD2 1University of California San Diego, 2University of California, San Diego

4C: Engineering Biomaterials for Cardiac and Pulmonary Uses

Date: Thursday, March 26, 2026
Time: 1:30 PM to 3:30 PM

Description

Advances in biomaterial design and microfabrication are enabling the creation of sophisticated in vitro models that recapitulate the cardiac and pulmonary microenvironments, offering new pathways for therapeutic development and disease understanding. These engineered platforms are being applied to develop treatments for acute conditions like viral infections, investigate chronic diseases such as fibrosis, and conduct testing to potentially reduce reliance on animal models. This session will further explore cutting-edge applications of biomaterials as both research tools and advanced therapeutics in cardiac and pulmonary medicine.

Moderators:

Claudia Loebel, M.D.
University of Pennsylvania

Yi Hong. Ph.D
Associate Professor of Bioengineering at UT Arlington
The University of Texas at Arlington

  • 1:30 PM. 172. Engineering Controlled-Size Lung Organoids for Physiological in vitro Modeling of the Alveolar Epithelium.Kerry Rogy1, Ha Ram Nah1, David Habiel2, Salman Khetani1 1University of Illinois Chicago, 2Sanofi
  • 1:45 PM. 173. Cardiac bilayer tissues modeling cardiomyocyte-mediated fibrotic switch of myofibroblasts.Emmanouil Agrafiotis, PhD1, Samuel J. DePalma, PhD2, Gonzalo Anyosa1, Katie Kim3, Darcy D. Huang4, Anya G. Coffeen Vandeven5, Austin E. Stis6, Jingyi Xia1, Brendon M. Baker, PhD3 1UNIVERSITY OF MICHIGAN, 2Broad Institute, 3UNIVERSITY OF MICHIGAN- ANN ARBOR, 4University of Pennsylvani, 5HSS/Weill Cornell, 6University of Florida
  • 2:00 PM. 174. A Micro-Engineered Heart Tissue Model of Desmin-related Cardiomyopathy Caused by Mutant B Crystallin.Yasaman Kargar Gaz Kooh1, Bahareh Bahman1, Chen Zhao2, Ganesh Malayath1, Leah Hayem1, Ghiska Ramahdita1, Huanzhu Jiang1, Javier Santiago Perez3, Hsin Yi Chou1, Yuxuan Huang1, Xiucui Ma3, Guy Genin1, David Rawnsley3, Abhinav Diwan3, Nathaniel Huebsch1 1Washington University in St. Louis, 2Washington Unicersity in St. Louis School of Medicine, 3Washington University in St. Louis School of Medicine
  • 2:15 PM. 175. A Compartmentalized Microphysiological System Modeling Bidirectional Crosstalk Between Activated Myofibroblasts and Proximal Microvasculature.Kairav Maniar, B.S.1, Jingyi Xia1, Brendon M. Baker, PhD2 1University of Michigan, 2UNIVERSITY OF MICHIGAN- ANN ARBOR
  • 2:30 PM. 176. Suspension-based Cardiac Differentiation of HiPSCs Using Scaffold-Free Aggregates and Poly(Ethylene Glycol) Fibrinogen Microspheres Impacts Cell Populations, Cardiomyocyte Yield and Tissue Function.B Justin Harvell1, Shireen Singh1, Carissa A Lee2, Nikolas D Ferreira2, Francisco X Galdos2, Mohammadjafar Hashemi1, Sidra Y Xu2, Shenbageshwaran Rajendiran1, Selen Cremaschi, PhD1, Sean M Wu, MD, PhD2, Elizabeth Lipke, PhD1 1Auburn University, 2Stanford University
  • 2:45 PM. 177. Improving Satellite Cell Delivery for Treating Peripheral Artery Disease via Platelet-Like Particle-Laden Fibrin Gels.Jared Albert1, Isabel Wallgren2, Lana Maizel1, Laura Hansen2, Ashley Brown, PhD1 1North Carolina State University, 2Emory University
  • 3:00 PM. 178. Stiffness and Integrin Binding Influence Alveolar Epithelial Cell Plasticity.Mikala Mueller, MS1, Rachel Blomberg, PhD1, Anton Kary, BS1, Bradford Smith, PhD1, Amy Ryan, PhD2, Chelsea Magin, BS, PhD1 1University of Colorado Denver | Anschutz, 2Carver College of Medicine, University of Iowa
  • 3:15 PM. 179. Developing an Electrically Conductive Cardiac Patch Encapsulating Genetically Modified Cardiomyocytes.Yamini Singh, M.Sc.1, Alejandra Patino-Guerrero, Ph.D.2, Kalpana Ravi, B.Tech.1, Wuqiang Zhu, MD, PhD2, Mehdi Nikkhah, Ph.D.1 1Arizona State University, 2Mayo Clinic

4D: Antimicrobial and Antibiofilm Biointerfaces: Strategies to Prevent Device-Associated Infections 1

Date: Thursday, March 26, 2026
Time: 1:30 PM to 3:30 PM
Room: Hanover AB

Description

Frontiers in Antimicrobial Biointerfaces: From Molecular Mechanisms to Material Design
Focus: This session highlights cutting-edge advances in understanding and engineering antimicrobial biointerfaces across length scales, from molecular design principles to functional biomaterial systems. Talks will focus on innovative strategies including self-sterilizing surfaces, antimicrobial mechanisms, engineered surface topographies, responsive nanostructures, and multifunctional hydrogels and scaffolds for infection control and tissue regeneration.

Moderators:

Matthew Libera
Professor | Department of Chemical Engineering and Materials Science
Charles V. Schaefer, Jr. School of Engineering and Science
Stevens Institute of Technology

Steven Nicoll
Professor | Biomedical Engineering
The City College of New York

  • 1:30 PM. 180. Self-sterilization in a Portable TiO2-catalyzed Dialysis Regeneration System.Ningjing Chen1, Buddy Ratner, Ph.D.1, James Bryers, Ph.D.1, Jonathan himmelfarb, MD2 1University of Washington, 2Icahn School of Medicine at Mount Sinai
  • 1:45 PM. 181. Small Molecule Tethered Silicone Biomaterials Surfaces Controlling Microbial Infection by Interfering with Nucleotide Second Messenger Signalling.Gaurav Pandey1, Parya Akram2, Christopher Siedlecki3, Li-Chong Xu3 1Pennsylvania State University, 2Penn State Harrisburg, 3Penn State College of Medicine
  • 2:00 PM. 182. Multiscale Insights into Peptoid Design for Self-Defensive Biomaterials.Anand Wadurkar1, Yu Liu1, Xuyang Qin1, Khuong Pham1, Wafiq Khondkar1, Shikha Nangia1 1Syracuse University
  • 2:15 PM. 183. Antifouling Urinary Catheters with Engineered Active Topographies.Zehui Han, B.S.1, Yikang Xu, Ph.D.2, Wenhan Zhao, Ph.D.1, Huan Gu, Ph.D.3, Teng Zhang, Ph.D.1, Dacheng Ren, Ph.D.4 1Syracuse University, 2University of Illinois at Urbana-Champaign, 3University of New Haven, 4University of Tennessee, Knoxville
  • 2:30 PM. 184.
  • 2:45 PM. 185. Hydrogel-based co-delivery of antimicrobial agents eliminates established infection and promotes bone healing.Luiza DaMotta, B.S.1, Eunice Chee, Ph.D.1, Jeremy Caplin, Ph.D.1, Andrés García, PhD1 1Georgia Institute of Technology
  • 3:00 PM. 186. Uniform and Controllable Deposition of PAA Microgels onto 3D-Printed PCL Scaffolds.Zhuozhuo Yin1 1stevens insitute of technonlgy
  • 3:15 PM. 187. Impact of Sterilization Methods on the Functional Properties of Injectable Methylcellulose-Based Hydrogels.Li-Chianne Tucker1, Sharon Zhou2, Meghan Halloran3, Adam Weisel3, David Alpert3, Karin Sauer2, Steven Nicoll, Ph.D.3 1The City College of New York, 2Binghamton University, 3CUNY City College of New York

4E: Hemocompatability and Blood Symposium 1

Date: Thursday, March 26, 2026
Time: 1:30 PM to 3:30 PM
Room: Hanover CDE

Description

Biomaterial surfaces commonly initiate blood coagulation, posing a major barrier to the safe and effective use of blood-contacting devices such as stents, vascular grafts, catheters, and mechanical heart valves. In recent years, there has been a declining emphasis on investigating material-induced thrombosis and the development of novel materials and strategies to mitigate these challenges. This symposium will explore emerging strategies to enhance hemocompatibility, including surface passivation, bioactive coatings, and controlled release of anticoagulant agents. Topics will include mechanisms of blood-material interactions, thrombosis modeling, and translational approaches to improving vascular device performance.

Moderators:

Liszet Yeltsin Madruga
George Mason University

Elizabeth Brisbois, Ph.D
School of Chemical, Materials & Biomedical Engineering | Associate Professor | Distinguished Faculty Fellow
University of Georgia

Chris Siedlicki, MS, PhD
Jane A. Fetter Professor | Surgery
Penn State College of Medicine

Hitesh Handa, Ph.D
Professor and Regents' Entrepreneur
University of Georgia

  • 1:30 PM. 188. Overview of New FDA Regulatory Science Tools (RSTs) for In Vitro Thrombogenicity Testing of Blood-contacting Medical Devices and Biomaterials. Qijin Lu, Megan Jamiolkowski, Mehulkumar Patel, Richard Malinauskas, Prasanna Hariharan U.S. Food and Drug Administration (FDA) Speakers Dr. Qijin Lu
  • 2:00 PM. 189. Shear-Mediated Platelet Adhesion, Aggregation, and Embolization on Polyurethane.Ian Goetz1, Christopher Siedlecki2, Keefe Manning, PhD1 1The Pennsylvania State University, 2Penn State College of Medicine
  • 2:00 PM. 193. Epoxy-Derived Covalently Crosslinked Slippery Organogel Coating for Improved Hemocompatibility with In Vivo Rabbit Model.Myddelton Parker1, Arpita Shome, Ph.D.1, Isabel Martinez1, Sumit Kumar, Ph.D.1, Tia Shorter1, Mark Garren, Ph.D.1, Meghan Lanchaster, DVM1, Ji Eun Park1, Chad Schmiedt1, Benjamin Brainard, VMD1, Elizabeth Brisbois, Ph.D.1, Hitesh Handa, Ph.D.1 1University of Georgia
  • 2:15 PM. 190. Robust Catalytic Nitric Oxide Generation from Metal-Phenolic Networks for Vascular Access Technologies.Mark Garren, Ph.D.1, Ekrem Ozkan, PhD1, Morgan Ashcraft, PhD1, Lori Estes-Bright, PhD1, Divine Francis, PhD1, Rashmi Pandey, PhD1, Natalie Crutchfield1, Anil Kumar, PhD2, Elizabeth Brisbois, Ph.D.1, Hitesh Handa, Ph.D.1 1University of Georgia, 2College of Engineering
  • 2:30 PM. 191. Thermoresponsive Chitosan-Based Hydrogel Coatings for Blood-Contacting Medical Devices.Ik Sung Cho1, Yasumichi Tsuboi1, Masaru Tanaka1 1Kyushu University
  • 2:45 PM. 192. Thrombogenicity of Transcatheter Aortic Valves and the Valve Biomaterial Components.Madelynn Tung1, Monica Hinds, PhD1, Deirdre Anderson, PhD1 1Oregon Health & Science University
  • 3:15 PM. 194. Minimizing Surface Interaction to Achieve Improved Hemocompatibility in Biomedical Surfaces.Christopher Siedlecki1, Gaurav Pandey2, Li-Chong Xu1 1Penn State College of Medicine, 2Pennsylvania State University

4F: Biomaterials for ImmunoEngineering

Date: Thursday, March 26, 2026
Time: 1:30 PM to 3:30 PM
Room: Hanover FG

Description

Over the past decade the focus of many bioengineers and clinicians has been shifting towards "immune engineering" approaches that include but are not limited to engineered biomaterials for vaccines, immunotherapy (immune modulation), cell and gene therapy, immune microenvironment engineering, and systems immunology. These research areas embrace a comprehensive list of translational immunology-associated problems including chronic infections, autoimmune diseases, aggressive cancers, allergies, etc. The purpose of the Immune Engineering SIG is to bring together emerging ideas and provide a venue for professional interaction to a large number of academic and industrial research groups and scientists working in these areas.

  • 1:30 PM. 195. Checkpoint Inhibition Accelerates Plasma Cell Differentiation in Human Immune Organoids.Ankur Singh1, Zhe Zhong1 1Georgia Institute of Technology
  • 1:45 PM. 196. Decellularized Lymph Node Platform Reveals Extracellular Matrix-Dependent Reprogramming of Fibroblastic Reticular Cells in Type 1 Diabetes Models.Leonor Teles, BS1, Marvin Mendoza, BS, MS1, Estefania Esparza, BS, MS1, Noa Dehaseth, BS1, Noel Ziebarth, PhD1, Mira Sayegh1, Alice Tomei2, Mauro Infante, BS1 1University of Miami, 2University of Miami, Diabetes Research Institute
  • 2:00 PM. 197. Development of a Maternal Vesicle Vaccine Against Group B Streptococcus with Enhanced Immune Responses.Mariela Rodriguez-Otero1, Julie Champion, PhD1, Aidan Keelaghan2, Fikri Avci, PhD2 1Georgia Institute of Technology, 2Emory University
  • 2:15 PM. 198. Polymeric Phosphatidyl Serine Antigen Conjugates Induce Antigen-Specific Tolerance.Mengheng Yang1, Sandeep Kumar1, Sabrina Chen1, Ian McKnight1, Stephane Lajoie1, Scott Wilson1 1Johns Hopkins
  • 2:30 PM. 199. Age-related Heterogeneity of Systemic Gene Expression Impairs Immune Responses to mRNA Lipid Nanoparticle Cancer Vaccines.Yining Zhu, PhD1, Christine Wei, BS1, Jingyao Ma, MSE1, Di Yu1, Hai-Quan Mao, PhD1 1Johns Hopkins University
  • 2:45 PM. 200. Engineering an Immunostimulatory Niche to Potentiate mRNA Lipid Nanoparticle Cancer Vaccines.Jingyao Ma, M.S.1, Yining Zhu, PhD1, Kailei Goodier, M.S.1, Xiang Liu, PhD1, Junru Liao1, Milun Jain1, Christine Wei, BS1, Di Yu1, Xiaoya Lu, MS1, Yunhe Su, M.S.1, Jinghan Lin, M.S.1, Hai-Quan Mao, PhD1 1Johns Hopkins University
  • 3:00 PM. 201. Microribbon Scaffolds Induce Hair Follicle Neogenesis in Skin Wounds by Modulating Neutrophil NETosis.Iris Qu1, Sungwon Kim, PhD1, Aidan Cabral, B.S.1, Hawa Thiam, PhD1, Fan Yang, PhD1 1Stanford University
  • 3:15 PM. 202. Synergistic Cell Therapy Potential of Tolerogenic Human Placental Trophoblasts Characterization in a Xenograft Model.Chishiba Chilimba, MS1, Shivani Hiremath, MS1, Jessica Weaver, Ph.D.1 1Arizona State University

4G: Biomaterials for Neural Engineering 1

Date: Thursday, March 26, 2026
Time: 1:30 PM to 3:30 PM
Room: GH East AB

Description

Engineered biomaterials are a centerpiece of new therapeutic approaches to treat neural injury as systems to deliver molecular and cell-based therapies to regenerate neural circuits or as components in closed-loop neurotechnologies. Biomaterials innovations that can improve the delivery of small molecules, biologics or cells to neural tissue, direct neuronal functional states, guide neural circuity connectivity, and improve neural cell interactions with devices hold the key to realizing new effective therapies. Furthermore, engineered biomaterials are uniquely positioned for use in creating, testing, and regenerating neural tissue with applications like in vitro models of injury and disease, brain organoid models, tissue engineering, therapeutic treatments, understanding neural development, and mapping the brain. This session will focus on cutting edge research in neural biomaterials including fundamental materials development work through pre-clinical and clinical studies. These include big questions surrounding understanding and treating neurological diseases and injuries of the peripheral and central nervous systems as well as drug, biologic, and cellular therapy delivery and neural interfacing. This session will be of significant interest to industry, academia, and clinical groups working in a broad array of neural engineering fields.

Moderators:

Shelly Sakiyama-Elbert
Professor and Vice Dean of Research and Graduate Education
College of Engineering & UW Medicine
University of Washington

Sarah Stabenfeldt, Ph.D
Knowledge Enterprise Fellow and President's Professor
School of Biological and Health Systems Engineering
Arizona State University

Kyle Lampe
Assistant Professor of Chemical Engineering
University of Virginia

  • 1:30 PM. 203. Biopolymeric, biodegradable, conductive hydrogels to promote human neural maturation.Fotis Christakopoulos, PhD1, Michelle Huang1, Carla Huerta-López, PhD1, Neil Baugh1, Vanessa Doulames, PhD1, Clélia Messin-Roizard1, Narelli de Paiva Narciso1, Sarah Heilshorn, PhD1 1Stanford University
  • 1:45 PM. 204. Hydrogel-Delivery of hiPSC-Cortical Neurons from Different Patient Lines Improves Anatomical and Functional Outcomes After Chronic Cervical Spinal Cord Injury.Vanessa Doulames, PhD1, Meghan Hefferon, B.S.1, Neil Baugh1, Christopher Long, BS1, Michelle Huang1, Theo Doulames, PhD2, Sarah Heilshorn, PhD1 1Stanford University, 2Stanford University School of Medicine
  • 2:00 PM. 205. Using Peptide Stereocomplexation to Engineer Hydrogel Degradation and Direct Neural Stem Cell Fate.Paul Eisold1, Diana Kirilov2, Emani Glover3, Kyle Lampe, PhD1 1University of Virginia, 2Merck, 3North Carolina Agricultural and Technical State University
  • 2:15 PM. 206. Trehalose coacervate formulation parameters determine glial cell interactions.Laboni Hassan1, Timothy O'Shea, PhD1 1Boston University
  • 2:30 PM. 207. Investigating Differential Axon Growth Between Biomimetic Substrates after Spinal Cord Injury.Hayley Lindsay1, Sangamithra Vardhan1, Shelly Sakiyama-Elbert1 1University of Washington
  • 2:45 PM. 208. N-Acetylcysteine Loaded Microparticles for Oxygen Glucose Deprivation/Reperfusion: Reactive Oxygen Species Quantification and Timing Implications in Neural Stem Cells.Nadeesani Sirinayake, PhD candidate1, Kyle Lampe, PhD1 1University of Virginia
  • 3:00 PM. 209. Noninvasive Nerve Regeneration via Intramuscularly Injected Nanoparticles.Jessica Larsen, PhD Chemical Engineering1 1Clemson University
  • 3:15 PM. 210. Soft, Precision Porous Scaffolds Promote Angiogenesis and Potential Neurogenesis in Adult Rat Brains.Le Zhen, PhD1, Ian Dryg, PhD2, Ningjing Chen1, Lars Crawford, PhD1, Buddy Ratner, Ph.D.1 1University of Washington, 2Dana-Farber Cancer Institute

4H: 3D Bioprinting for Developing Personalized Models 1

Date: Thursday, March 26, 2026
Time: 1:30 PM to 3:30 PM
Room: GH East CD

Description

Three dimensional (3D) bioprinting is a practical and commonly accessible biofabrication tool for a wide range of applications in tissue engineering and regenerative medicine because it has a unique ability to precisely position bioinks, cells, and/or biomolecules into spatially organized structures. 3D bioprinting can be conveniently used to develop personalized implants, in vitro disease models, and drug screening platforms as well as tissue replacements. In this session, we will highlight the advances and recent trends in 3D bioprinting technologies, development of multi-functional biomaterials, novel bioink formulations, clinical translation of bioprinting, current challenges and future perspectives, 4D bioprinting, and a wide range of medical
applications of 3D bioprinting approaches. In addition, we will cover multi-scale manipulatio strategies for biomaterials and cells to engineer physiologically relevant 3D in vitro models, and emerging advances in 4D printing of stimuli-responsive biomaterials for precision medicine.

Moderators:

Murat Guvendiren
Associate Professor, Chemical & Materials Engineering
New Jersey Instittue of Technology

Dr. Gulden Camci-Unal
Professor | Chemical Engineering, Center for Pathogen Research & Training (CPRT)
UMass Lowell

  • 1:30 PM. 211. Mitigating Bioprinting Stress: Engineering Bioinks to Control YAP/TAZ-Mediated Cellular Reprogramming.Thomas Boland, PhD1, Patricia Ablanedo Morales, PhD1, Jonah Ayala, BS1, April Ruiz, none1, Ramon Holguin, none1 1The University of Texas at El Paso
  • 1:45 PM. 212. Bioprinting Strategically Aligned Collagen Fibers and Bioactive Bone Layers for Osteochondral Construct.Hang Truong1, Murat Guvendiren1 1New Jersey Institute of Technology
  • 2:00 PM. 213. Two Photon Mediated Fabrication of Next Generation Aligned Collagen Scaffolds.Wesley Nichols, B.S.1, Bruce Gao1, Lucas Schmidt, Ph.D2, Luke Peterson2 1Clemson University, 2Clemson Univeristy
  • 2:15 PM. 214. Flow-Driven Hydrogel Fiber Micro-compartmentalization for the high-throughput generation of multicellular 3D cancer models.Carlos Guimarães1, Ramon Silva1, Bruna Correia1, Rui Reis1 1University of Minho
  • 2:30 PM. 215. Implantable prevascularized engineered human liver tissues with controlled microenvironmental cues.Ha Ram Nah1, Kerry Rogy1, Xin Li, PhD2, Ramille Shah, PhD2, Salman Khetani1 1University of Illinois Chicago, 2Dimension Bio
  • 2:45 PM. 216. High-Density, Extrudable Collagen-Based Inks for Tissue Engineering Applications.Kevin Capariño, M.S.E.1, Shu-Tung Li, PhD1 1Shu-Tung and Alice Li Foundation: Laboratory for Tissue Engineering Research
  • 3:00 PM. 217. Organoids Bioprinting to Establish Liver Cancer Model for High-Throughput Drug Screening.Zhenhua Cui1, Min Wang1 1The University of Hong Kong
  • 3:15 PM. 218. Ultrasound-Controlled Genetic Manipulation of Cells and Spheroids in FRESH 3D-Bioprinted Tumor Models.Mary Lowrey1, Holly Day1, Kevin Schilling, PhD2, Kira Lynch1, Anthony Tahayeri1, Luiz Bertassoni, DDS, PhD1, Carolyn Schutt Ibsen, PhD1 1Oregon Health and Science University, 2Oregon Health& Science University